Article Text

other Versions

PDF
A Gain-of-function TBX20 Mutation Causes Congenital Atrial Septal Defects, Patent Foramen Ovale and Cardiac Valve Defects
  1. Maximilian G Posch (maximilian.posch{at}charite.de)
  1. ECRC - Charité-Universitatsmedizin Berlin, Germany
    1. Michael Gramlich (m.gramlich{at}victorchang.edu.au)
    1. Victor Chang Cardiac Research Institute, Australia
      1. Margaret Sunde (m.sunde{at}mmb.usyd.edu.au)
      1. School of Molecular and Microbial Biosciences, University of Sydney, Australia
        1. Katharina Schmitt
        1. German Heart Institute, Germany
          1. Silke Richter
          1. ECRC - Charité-Universitatsmedizin Berlin, Germany
            1. Andreas Perrot
            1. ECRC - Charité-Universitatsmedizin Berlin, Germany
              1. Anna N Panek
              1. ECRC - Charité-Universitatsmedizin Berlin, Germany
                1. Iman Al Khatib
                1. American University of Beirut (AUB), Beirut, Lebanon, Lebanon
                  1. Georges Nemer
                  1. American University of Beirut (AUB), Beirut, Lebanon, Lebanon
                    1. André Megarbane
                    1. St. Joseph University, Beirut, Lebanon, Lebanon
                      1. Rainer Dietz
                      1. ECRC - Charité-Universitatsmedizin Berlin, Germany
                        1. Brigitte Stiller
                        1. University of Freiburg, Germany
                          1. Felix Berger
                          1. German Heart Institute, Germany
                            1. Richard P Harvey
                            1. Victor Chang Cardiac Research Institute, Australia
                              1. Cemil Özcelik
                              1. ECRC - Charité-Universitatsmedizin Berlin, Germany

                                Abstract

                                Background: Ostium secundum atrial septal defects (ASDII) account for approximately 10% of all congenital heart defects (CHD) and mutations in cardiac transcription factors, including TBX20, were identified as an underlying cause for ASDII. However, very little is known about disease penetrance in families and functional consequences of inherited TBX20 mutations.

                                Methods: The coding region of TBX20 was directly sequenced in 170 ASDII patients. Functional consequences of one novel mutation were investigated by surface plasmon resonance, CD spectropolarymetry, fluorescence spectrophotometry, luciferase assay and chromatin immunoprecipitation.

                                Results: We found a novel mutation in a highly conserved residue in the T-box DNA-binding domain (I121M) segregating with CHD in a three generation kindred. Four mutation carriers revealed cardiac phenotypes in terms of cribriform ASDII, large patent foramen ovale or cardiac valve defects. Interestingly, tertiary hydrophobic interactions within the mutant TBX20 T-box were significantly altered leading to a more dynamic structure of the protein. Moreover, Tbx20-I121M resulted in a significantly enhanced transcriptional activity, which was further increased in the presence of co-transcription factors GATA4/5 and NKX2-5. Occupancy of DNA binding sites on target genes was also increased.

                                Conclusions: We suggest that TBX20-I121M adopts a more fluid tertiary structure leading to enhanced interactions with cofactors and more stable transcriptional complexes on target DNA sequences. Our data, combined with that of others, suggest that human ASDII may be related to loss- as well as gain-of-function TBX20 mutations.

                                Statistics from Altmetric.com

                                Request permissions

                                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.